<html>
<head>PUBMED IDs for MAGEC2</head>
<body bgcolor='#C5F0F2'><h1>MAGEC2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16929165/'>Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma.</a> August 25  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17023585/'>Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.</a> October 7  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18426187/'>Cancer-testis (CT) antigen expression in medulloblastoma.</a> April 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18426139/'>Development of an inhaled endotoxin challenge protocol for characterizing evoked cell surface phenotype and genomic responses of airway cells in allergic individuals.</a> April 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21780320/'>MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.</a> September 23  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24795360/'>Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions.</a> December 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25576290/'>Primary mediastinal seminomas: a comprehensive immunohistochemical study with a focus on novel markers.</a> May 20  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26456863/'>Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma.</a> May 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27636589/'>Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells.</a> September 17  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28342986/'>Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes.</a> March 27  2017<br></body></html>
